WhitTier Trust Company’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2K Hold
7,141
﹤0.01% 915
2026
Q1
$19.5K Hold
7,141
﹤0.01% 909
2025
Q4
$24.2K Hold
7,141
﹤0.01% 867
2025
Q3
$31.8K Hold
7,141
﹤0.01% 787
2025
Q2
$20.4K Hold
7,141
﹤0.01% 985
2025
Q1
$19.3K Hold
7,141
﹤0.01% 975
2024
Q4
$16.8K Hold
7,141
﹤0.01% 979
2024
Q3
$16.9K Hold
7,141
﹤0.01% 969
2024
Q2
$13.9K Hold
7,141
﹤0.01% 952
2024
Q1
$45.9K Hold
7,141
﹤0.01% 699
2023
Q4
$100K Buy
+7,141
New +$113K ﹤0.01% 564

Other funds holding GNLX

WhitTier Trust Company's GNLX Position: Q2 2026 in Review

WhitTier Trust Company held its Genelux (GNLX) position steady in Q2 2026 at 7,141 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #915.

WhitTier Trust Company first reported a position in GNLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $100K in Q4 2023. 38 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • WhitTier Trust Company held 7,141 shares of Genelux worth $21.2K as of Q2 2026.
  • WhitTier Trust Company left its Genelux share count unchanged in Q2 2026.
  • Genelux made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #915 holding.
  • WhitTier Trust Company first reported a position in Genelux in Q4 2023 and has held it in 11 quarters since.
  • WhitTier Trust Company's Genelux position peaked at $100K in Q4 2023.
  • 38 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.